DYN - Dyne Therapeutics, Inc.

QQQ $ 456.91 $ 0.55 (0.12 %)

DIA $ 407.29 $ -2.32 (-0.57 %)

SPY $ 547.12 $ -1.27 (-0.23 %)

TLT $ 100.72 $ 0.81 (0.82 %)

GLD $ 232.32 $ -0.09 (-0.04 %)

Previous Close

$ 32.47

Open

$ 32.24

Bid

$ 32.26 x 120

Ask

-- x --

Day's Range

$ 31.01 - $ 32.38

52 Week Range

$ 6.40 - $ 47.45

Volume

1,210,620

Average Volume

Market Cap

3.26B

Beta (5Y Monthly)

$ 0.87

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-05-2024	12-31-2023	10-K
4	10-30-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-02-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-04-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Dyne...
09/04/2024 11:32:06

HC Wainwright & Co. analyst Andrew Fein reiterates Dyne Therapeutics (NASDAQ:DYN) with a Buy and maintains $55 price tar...

Crude Oil Dips Over 4%; SPAR Group Shares ...
09/03/2024 18:59:54

Oppenheimer Reiterates Outperform on Dyne ...
09/03/2024 17:52:03

Oppenheimer analyst Francois Brisebois reiterates Dyne Therapeutics (NASDAQ:DYN) with a Outperform and maintains $55 price t...

why-recursion-pharmaceuticals-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Recursion Pharmaceuticals Shares Are T...
09/03/2024 17:41:09

muscle-disease-drug-developer-dyne-therapeutics-stock-plunges-after-updated-data-from-duchenne-muscular-dystrophy

Muscle Disease Drug Developer Dyne Therape...
09/03/2024 16:37:01

Dyne Therapeutics revealed new clinical data from its Phase 1/2 DELIVER trial of DYNE-251 for Duchenne muscular dystrophy, show...

nasdaq-dips-over-2-us-construction-spending-falls-in-july

Nasdaq Dips Over 2%; US Construction Spend...
09/03/2024 16:00:51

dow-tumbles-1-ism-manufacturing-pmi-misses-estimates

Dow Tumbles 1%; ISM Manufacturing PMI Miss...
09/03/2024 14:19:40

boeing-dyne-therapeutics-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Boeing, Dyne Therapeutics And Other Big St...
09/03/2024 12:03:44

Dyne Therapeutics Announced New Clinical D...
09/03/2024 10:32:20

Initiating Registrational Cohorts with Update on Path to Registration by Year-End 2024

Stifel Maintains Buy on Dyne Therapeutics,...
08/16/2024 12:50:55

Stifel analyst Paul Matteis maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $41 to $66.

Guggenheim Maintains Buy on Dyne Therapeut...
08/15/2024 17:16:11

Guggenheim analyst Debjit Chattopadhyay maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from...

Morgan Stanley Maintains Overweight on Dyn...
08/14/2024 12:00:37

Morgan Stanley analyst Michael Ulz maintains Dyne Therapeutics (NASDAQ:DYN) with a Overweight and raises the price target fr...

tech-stocks-soar-treasury-yields-fall-on-cool-inflation-data-starbucks-rockets-chipotle-plummets-whats-driving-markets-tuesday

Tech Stocks Soar, Treasury Yields Fall On ...
08/13/2024 16:55:01

A wave of bullish sentiment swept through Wall Street on Tuesday after lower-than-expected producer inflation data solidified e...

Piper Sandler Maintains Overweight on Dyne...
08/13/2024 11:13:16

Piper Sandler analyst Edward Tenthoff maintains Dyne Therapeutics (NASDAQ:DYN) with a Overweight and raises the price target...

HC Wainwright & Co. Maintains Buy on Dyne ...
08/13/2024 10:35:28

HC Wainwright & Co. analyst Andrew Fein maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target ...

Dyne Therapeutics Expects Cash & Equivalen...
08/12/2024 21:21:59

Dyne Therapeutics Q2 2024 GAAP EPS $(0.70)...
08/12/2024 21:19:42

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0....

xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details

XPeng & QuantumScape Are Among Top 11 Mid ...
07/14/2024 17:22:37

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

JP Morgan Maintains Overweight on Dyne The...
07/09/2024 15:01:22

JP Morgan analyst Tessa Romero maintains Dyne Therapeutics (NASDAQ:DYN) with a Overweight and raises the price target from $...

Dyne Therapeutics DYNE-302 Exhibited Prolo...
06/13/2024 20:43:53